United States · FDA National Drug Code directory
Ryzumvi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83368-075_5652e1c3-6e06-457d-86f5-b05d5b399878
- Product NDC
- 83368-075
- Form
- SOLUTION/ DROPS
- Composition / generic term
- phentolamine mesylate
- Labeler
- Oyster Point Pharma, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240325
- Source listing expiry
- 20271231
Source-listed ingredients
- PHENTOLAMINE MESYLATE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 POUCH in 1 CARTON (83368-075-30) / 5 VIAL, SINGLE-USE in 1 POUCH / .2 mL in 1 VIAL, SINGLE-USE · 83368-075-30
- 1 POUCH in 1 CARTON (83368-075-31) / 5 VIAL, SINGLE-USE in 1 POUCH / .2 mL in 1 VIAL, SINGLE-USE · 83368-075-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →